Status:
UNKNOWN
Hemodynamic Assessment in Cardiogenic Shock Regarding the Etiology
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Cardiogenic Shock
Eligibility:
All Genders
18+ years
Brief Summary
The classic physiopathology of cardiogenic shock is explained by a systolic ventricular failure, responsible for a decrease in cardiac output associated with high systemic vascular resistances (SVR). ...
Eligibility Criteria
Inclusion
- Persistent hypotension (systolic blood pressure \<90 mmHg for at least 30 minutes or need for vasopressor support)
- Signs of visceral hypoperfusion (confusion, marbling, oliguria, hyperlactataemia), 11
- Lower heart rate (\<1.8 L / min / m2) Adap Suitable or high filling pressures12
Exclusion
- Pregnant or nursing women
- Major under guardianship
- Person staying in a health or social facility
- Non-beneficiaries of a social security scheme
- Persons deprived of liberty
- No one is able to give consent.
Key Trial Info
Start Date :
September 6 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2019
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT03283995
Start Date
September 6 2017
End Date
March 1 2019
Last Update
April 11 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assisatnce Publique Hopitaux de Marseille
Marseille, France